Viewing Study NCT05164250


Ignite Creation Date: 2025-12-24 @ 5:12 PM
Ignite Modification Date: 2026-02-21 @ 4:08 AM
Study NCT ID: NCT05164250
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2025-11-10
First Post: 2021-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)
Sponsor: Regeneron Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed, Refractory View